Fritextsökning
Innehållstyper
-
Did you know that not every sphere is really a round sphere?
ZEISS Metrology Expert Tip.
-
“Life science is important on a personal level”
From the High Coast to the Government Offices. Jeanette Edblad is a native of Ångermanland, and since September last year, she has been Head and Coordinator of ...
-
Pulsen på patientförbunden del 4: Ung Cancer
”Engagemang och vilja finns, det gäller bara att hitta rätt former”, säger Therese Leijon, Ung Cancer, i Life Science Swedens artikelserie Pulsen på patientförbunden.
-
Kennedy stoppar 22 projekt inom mRNA-vaccin – experter varnar för följderna
USA:s hälsodepartement avbryter finansieringen av 22 projekt som utvecklar mRNA-baserade vacciner, och växlar över till vad som hävdas vara ”säkrare och bredare...
-
”We need compatibility“
Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...
-
ZEISS Quality Innovations at CONTROL
May 6-9, 2025 in Stuttgart.
-
Assignment: Facilitate the retention of foreign researchers
A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.
-
Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”
“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...
-
The new ZEISS Celldiscoverer 7 has been launched
Adaptable automation for advanced workflows.
-
Final assembly inspection of medical plastics
Technical paper by ZEISS Medical Industry Solutions.
-
Hello Angelica Loskog!
Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.
-
The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality
Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...
-
ZEISS Metrology Expert Tips
New video series provides valuable expert knowledge.
-
Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience
Case study by ZEISS Microscopy.
-
It couldn’t be simpler
AI-assisted ZEISS Solution inspects implant coatings automatically.
-
Novo Nordisk köper antikropp – för miljardbelopp
Danska läkemedelsjätten Novo Nordisk har tecknat avtal med det amerikanska bioteknikföretaget Omeros Corporation om att förvärva och vidareutveckla en antikropp...
-
Effektiv och hygienisk nivåmätning med radar från OEM Automatic
OEM Automatic erbjuder radarnivågivare från Rosemount – en lösning för beröringsfri nivåmätning som kombinerar precision, pålitlighet och lång livslängd. Teknik...
-
Improve Productivity and Accessibility with Award-winning Human-Centered Design
Enhance your workflow with integrated intelligence.
-
Venom from the deathstalker carries radiopharmaceuticals to the brain
In order to target cancerous brain tumours with radionuclides, the problematic blood-brain barrier must first be crossed. Life Science Sweden has visited a KI r...
-
Raised millions to develop a treatment for ´butterfly children´
Fragile as a butterfly’s wing – that’s how people living with Epidermolysis Bullosa are usually described. The Lund-based company Xinnate recently raised SEK 100 million in a new...
-
“An entire industry is about to be wiped out”
According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
”Information security must become part of the Swedish life science strategy”
Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.
-
Fuskanklagat pharmabolag lägger ner alzheimerprojekt
Amerikanska Cassava Sciences avbryter utvecklingen av sin läkemedelskandidat inom Alzheimers sjukdom efter misslyckande i en fas III-studie
BREAKING